Wu Hansen, Xu Jie, Zhao Wenxuan, Lv Weiqiang, Feng Zhihui, Heng Lijun
Frontier Institute of Science and Technology, Xi'an Jiaotong University, Xi'an 710049, China.
Center for Mitochondrial Biology and Medicine, The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an 710049, China.
Antioxidants (Basel). 2024 Dec 11;13(12):1514. doi: 10.3390/antiox13121514.
Pituitary adenoma is a common neoplasm of the pituitary gland. Although most pituitary adenomas are benign, they can pose significant challenges in terms of their consequences and prognosis due to their tendency to invade surrounding tissues and their effects on hormone secretion. The management of pituitary adenomas typically involves surgery, medical therapy, and radiotherapy, each of which has its own limitations. Mitochondria play a crucial role in tumor development and progression by regulating various metabolic processes and signaling pathways within tumor cells and the tumor microenvironment. Multiple studies have indicated that mitochondrial dysfunction is implicated in human pituitary adenomas. Furthermore, several compounds with therapeutic effects on pituitary adenomas have been reported to target mitochondrial function. In this review, we summarize recent studies that highlight the involvement of mitochondrial homeostasis imbalance in the biology of pituitary adenomas. We conclude that mitochondria may represent a promising therapeutic target for the treatment of pituitary adenomas.
垂体腺瘤是垂体的一种常见肿瘤。尽管大多数垂体腺瘤是良性的,但由于它们倾向于侵犯周围组织以及对激素分泌的影响,其后果和预后可能带来重大挑战。垂体腺瘤的治疗通常包括手术、药物治疗和放射治疗,每种治疗方法都有其局限性。线粒体通过调节肿瘤细胞和肿瘤微环境内的各种代谢过程和信号通路,在肿瘤的发生和发展中起着至关重要的作用。多项研究表明,线粒体功能障碍与人类垂体腺瘤有关。此外,据报道,几种对垂体腺瘤有治疗作用的化合物靶向线粒体功能。在这篇综述中,我们总结了最近的研究,这些研究突出了线粒体稳态失衡在垂体腺瘤生物学中的作用。我们得出结论,线粒体可能是治疗垂体腺瘤的一个有前景的治疗靶点。